EOLS
Price
$6.40
Change
+$0.10 (+1.59%)
Updated
Oct 17 closing price
Capitalization
413.99M
23 days until earnings call
RDHL
Price
$1.50
Change
-$0.07 (-4.46%)
Updated
Oct 17 closing price
Capitalization
4.99M
45 days until earnings call
Interact to see
Advertisement

EOLS vs RDHL

Header iconEOLS vs RDHL Comparison
Open Charts EOLS vs RDHLBanner chart's image
Evolus
Price$6.40
Change+$0.10 (+1.59%)
Volume$532.82K
Capitalization413.99M
Redhill Biopharma
Price$1.50
Change-$0.07 (-4.46%)
Volume$55.75K
Capitalization4.99M
EOLS vs RDHL Comparison Chart in %
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. RDHL commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a Hold and RDHL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (EOLS: $6.40 vs. RDHL: $1.50)
Brand notoriety: EOLS and RDHL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EOLS: 53% vs. RDHL: 4%
Market capitalization -- EOLS: $413.99M vs. RDHL: $4.99M
EOLS [@Pharmaceuticals: Generic] is valued at $413.99M. RDHL’s [@Pharmaceuticals: Generic] market capitalization is $4.99M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, RDHL is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 3 TA indicator(s) are bullish while RDHL’s TA Score has 4 bullish TA indicator(s).

  • EOLS’s TA Score: 3 bullish, 5 bearish.
  • RDHL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both EOLS and RDHL are a bad buy in the short-term.

Price Growth

EOLS (@Pharmaceuticals: Generic) experienced а +4.23% price change this week, while RDHL (@Pharmaceuticals: Generic) price change was -11.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Reported Earning Dates

EOLS is expected to report earnings on Nov 11, 2025.

RDHL is expected to report earnings on Dec 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EOLS($414M) has a higher market cap than RDHL($5M). EOLS YTD gains are higher at: -42.029 vs. RDHL (-75.845). RDHL has higher annual earnings (EBITDA): -29.5M vs. EOLS (-33.58M). EOLS has more cash in the bank: 61.7M vs. RDHL (7.28M). RDHL has less debt than EOLS: RDHL (558K) vs EOLS (155M). EOLS has higher revenues than RDHL: EOLS (278M) vs RDHL (3.71M).
EOLSRDHLEOLS / RDHL
Capitalization414M5M8,288%
EBITDA-33.58M-29.5M114%
Gain YTD-42.029-75.84555%
P/E RatioN/A0.09-
Revenue278M3.71M7,499%
Total Cash61.7M7.28M848%
Total Debt155M558K27,778%
FUNDAMENTALS RATINGS
EOLS vs RDHL: Fundamental Ratings
EOLS
RDHL
OUTLOOK RATING
1..100
696
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9165
P/E GROWTH RATING
1..100
10079
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDHL's Valuation (89) in the Biotechnology industry is in the same range as EOLS (92) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (81) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

EOLS's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

RDHL's Price Growth Rating (65) in the Biotechnology industry is in the same range as EOLS (91) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

RDHL's P/E Growth Rating (79) in the Biotechnology industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSRDHL
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGH5.910.90
+17.96%
Aureus Greenway Holdings Inc
ATEC14.890.63
+4.42%
Alphatec Holdings
GLPI44.830.23
+0.52%
Gaming and Leisure Properties
MRVI3.30-0.19
-5.44%
Maravai LifeSciences Holdings
ACON8.04-0.66
-7.59%
Aclarion Inc

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with PRGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+1.59%
PRGO - EOLS
46%
Loosely correlated
+0.42%
LNTH - EOLS
34%
Loosely correlated
-1.35%
AMRX - EOLS
32%
Poorly correlated
+0.51%
ALKS - EOLS
32%
Poorly correlated
-1.75%
NBIX - EOLS
29%
Poorly correlated
+1.87%
More

RDHL and

Correlation & Price change

A.I.dvisor tells us that RDHL and TLRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
-4.46%
TLRY - RDHL
29%
Poorly correlated
+1.30%
YCBD - RDHL
27%
Poorly correlated
+9.52%
ACET - RDHL
27%
Poorly correlated
-4.81%
EOLS - RDHL
25%
Poorly correlated
+1.59%
OGI - RDHL
23%
Poorly correlated
-3.70%
More